Skip to main content
. 2023 Dec 8;12(24):7575. doi: 10.3390/jcm12247575
COVID-19 coronavirus disease 2019
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
WHO World Health Organization
BSL biosafety level
PCR polymerase chain reaction
RBD receptor-binding domain
NTD N-terminal domain
ACE2 human angiotensin-converting enzyme 2
ELISA enzyme-linked immunosorbent assay
LFA lateral flow immunoassay
CLIA chemiluminescent immunoassay
FDA U.S. Food and Drug Administration
IU international units
BAU binding antibody units
CI confidence interval
aOR adjusted odds ratio
aHR adjusted hazard ratio